IRCT20240627062268N1尚未招募3 期
Evaluation of the efficacy of letrozole in the luteal phase compared to sterolix acetate in the prevention of premature ovarian hyperstimulation syndrome (OHSS): a single blind randomized clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 35 years（—）
- 性别
- Female
入选标准
- •Age of 20 to 35 years old
- •BMI 18 to 29 kg/m2
- •AMH level more than 4ng/ml
- •The number of antral follicles (AFC) in each ovary more than 12, confirmed by transvaginal ultrasound
- •Serum level of estradiol (E2) more than 4000 pg/ml on the trigger day
- •The number of punctured follicles more than 15 per ovary (follicular diameter of 14 mm on the day of egg retrieval)
排除标准
- •Contraindications for use of letrozole or cetrolix acetate include severe liver and kidney dysfunction
- •Women with estradiol (E2) level less than 4000 pg/ml in trigger day
研究者
相似试验
尚未招募
Unknown
Investigating the effect of letrozole in the treatment of ectopic pregnancyEctopic pregnancyIRCT20220902055855N1Tehran University of Medical Sciences75
已完成
3 期
Evaluation of the effect of letrozole in the prevention of ovarian hyperstimulation syndromeIRCT20180313039085N1Esfahan University of Medical Sciences40
已完成
2 期
Evaluation of efficacy of Letrozole on the duration and severity of Ovarian hyperstimulation syndromeIRCT20141008019464N2Kerman University of Medical Sciences40
已完成
2 期
Evaluation of the usefulness of letrozole as neoadjuvant hormone therapy for postmenopausal patients with hormone receptor-positive breast cancerBreast cancerJPRN-UMIN000003699St. Luke's International Hospital60
已完成
2 期
Evaluation of the usefulness of letrozole as hormone therapy for postmenopausal patients with Ductal Carcinoma In Situ (DCIS)Breast cancerJPRN-UMIN000000966St. Luke's International Hospital20